Amelia Orejudos

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

Andrew Blumenfeld, Richard Stark, Marshall C. Freeman et al. · The Journal of Headache and Pain · 2018 · 192 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

Adrian C. Newland, Bertrand Godeau, Victor Priego et al. · British Journal of Haematology · 2015 · 174 citations

Medicine, Hematology, Pharmacotherapy +11

Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety

Andrew Blumenfeld, Stewart J. Tepper, Lawrence Robbins et al. · Journal of Neurology Neurosurgery & Psychiatry · 2019 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long‐term safety and efficacy

Pierre Fenaux, Petra Muus, Hagop M. Kantarjian et al. · British Journal of Haematology · 2017 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study

Paul Winner, Andrew Blumenfeld, Eric J. Eross et al. · Drug Safety · 2019 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15